Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension. 1981

G A MacGregor, and S Fenton, and J Alaghband-Zadeh, and N Markandu, and J E Roulston, and H E de Wardener

A cytochemical technique that measures the ability of plasma to stimulate guinea-pig renal glucose-6-phosphate dehydrogenase (G6PD) activity in vitro, which is a marker of its ability to inhibit Na+-K+-adenosine-triphosphatase (Na+-K+-ATPase), was used in 19 patients with essential hypertension and 23 normotensive, healthy subjects. The ability of plasma to stimulate G6PD was significantly greater in the hypertensive patients when they were taking their normal sodium diet than in the normotensive subjects, and was significantly correlated with blood pressure. The ability of plasma to stimulate G6PD was inversely correlated with plasma renin activity in the hypertensive patients and increased with age and sodium intake in the normotensive subjects. These results support the hypothesis that essential hypertension, and also perhaps the increase in blood pressure with age in communities that consume large quantities of salt, is in part due to an increase in a circulating concentration of an inhibitor of Na+-N+-ATPase.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004039 Diet, Sodium-Restricted A diet which contains very little sodium chloride. It is prescribed by some for hypertension and for edematous states. (Dorland, 27th ed) Diet, Low-Salt,Diet, Low-Sodium,Diet, Salt-Free,Diet, Low Salt,Diet, Low Sodium,Diet, Salt Free,Diet, Sodium Restricted,Diets, Low-Salt,Diets, Low-Sodium,Diets, Salt-Free,Diets, Sodium-Restricted,Low-Salt Diet,Low-Salt Diets,Low-Sodium Diet,Low-Sodium Diets,Salt-Free Diet,Salt-Free Diets,Sodium-Restricted Diet,Sodium-Restricted Diets
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005260 Female Females
D005954 Glucosephosphate Dehydrogenase Glucose-6-Phosphate Dehydrogenase,Dehydrogenase, Glucose-6-Phosphate,Dehydrogenase, Glucosephosphate,Glucose 6 Phosphate Dehydrogenase

Related Publications

G A MacGregor, and S Fenton, and J Alaghband-Zadeh, and N Markandu, and J E Roulston, and H E de Wardener
March 1981, British medical journal (Clinical research ed.),
G A MacGregor, and S Fenton, and J Alaghband-Zadeh, and N Markandu, and J E Roulston, and H E de Wardener
April 1981, British medical journal (Clinical research ed.),
G A MacGregor, and S Fenton, and J Alaghband-Zadeh, and N Markandu, and J E Roulston, and H E de Wardener
January 1984, Journal of cardiovascular pharmacology,
G A MacGregor, and S Fenton, and J Alaghband-Zadeh, and N Markandu, and J E Roulston, and H E de Wardener
July 1980, La Nouvelle presse medicale,
G A MacGregor, and S Fenton, and J Alaghband-Zadeh, and N Markandu, and J E Roulston, and H E de Wardener
January 1981, Clinical and experimental hypertension,
G A MacGregor, and S Fenton, and J Alaghband-Zadeh, and N Markandu, and J E Roulston, and H E de Wardener
October 1985, Archives des maladies du coeur et des vaisseaux,
G A MacGregor, and S Fenton, and J Alaghband-Zadeh, and N Markandu, and J E Roulston, and H E de Wardener
December 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
G A MacGregor, and S Fenton, and J Alaghband-Zadeh, and N Markandu, and J E Roulston, and H E de Wardener
January 1986, Scandinavian journal of clinical and laboratory investigation. Supplementum,
G A MacGregor, and S Fenton, and J Alaghband-Zadeh, and N Markandu, and J E Roulston, and H E de Wardener
March 1986, Klinische Wochenschrift,
G A MacGregor, and S Fenton, and J Alaghband-Zadeh, and N Markandu, and J E Roulston, and H E de Wardener
January 1985, Clinical and experimental hypertension. Part A, Theory and practice,
Copied contents to your clipboard!